Abio-X
Waltham, Massachusettsabio-x.com
Overview
Abio-X is a biotechnology incubation platform that was founded by CBC Group in 2021 to create and invest in life sciences companies.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Adcentrx Therapeutics | Dec 2023 | Series A Extension | Co-investor |
| Pheon Therapeutics | May 2024 | Series B | - |
Key People
Sean Wuxiong Cao
Chief Executive Officer
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Abio-X based?
Abio-X is headquartered in Waltham, Massachusetts, United States.
When was Abio-X founded?
Abio-X was founded in 2021.
How many portfolio companies does Abio-X have?
Abio-X has 2 portfolio companies in Caplight's dataset.
What are some companies in Abio-X's portfolio?
Portfolio companies visible on Caplight include Adcentrx Therapeutics, Pheon Therapeutics.
What was Abio-X's most recent investment shown here?
Abio-X's most recent investment in this portfolio sample was in Pheon Therapeutics in 2024.
What sectors does Abio-X focus on?
Abio-X focuses on Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does Abio-X focus on?
Abio-X typically invests at the Early stage.
What is Abio-X's AUM?
Abio-X's assets under management are estimated between $150.0M and $150.0M.
See something wrong or outdated?